Brace Pharma Capital

ReViral raised $44M on August 25, 2020

Investors: New Leaf Venture Partners, OrbiMed Advisors, Andera Partners, Perceptive Advisors, Novo Holdings and Brace Pharma Capital

F2G raised $61M on August 12, 2020

Investors: Morningside Venture Capital 晨兴资本, Advent Life Sciences and Brace Pharma Capital

HotSpot Therapeutics, Inc. raised $65M on May 21, 2020

Investors: Atlas Venture, Tekla Capital Management, S.R. One Ltd, Solasta Ventures, Sofinnova Partners and Brace Pharma Capital

Pipeline Therapeutics raised $32M on December 18, 2019

Investors: Sectoral Asset Management, Versant Ventures, Helicase Venture, RBV Capital, Hadean Ventures and Brace Pharma Capital

Avidity Biosciences raised $100M on November 13, 2019

Investors: Alethea Capital Management LLC, -, Perceptive Advisors, Logos Global Management, LP, RTW Investments, LP, Takeda UK Limited and Brace Pharma Capital

Avidity Biosciences raised $16M on October 17, 2018

Investors: Alethea Capital Management LLC, Tavistock Group, F-Prime Capital Partners, Moore Venture Partners and Brace Pharma Capital

Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $15M on July 10, 2018

Investors: NS Investment, JLABS, Canaan, Sirona Capital, Osage University Partners (OUP), Hillhouse Capital Management, Sofinnova Ventures, Russia technology fund and Brace Pharma Capital

AVROBIO raised $60M on February 1, 2018

Investors: Leerink Partners LLC, Research Division, Aisling Capital, Atlas Venture, SV Life Sciences, Clarus Ventures, LLC, Morningside Venture Partners and Brace Pharma Capital

Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $22M on March 28, 2017

Investors: NS Investment, Sofinnova Ventures, Russia technology fund, Canaan, Osage University Partners (OUP) and Brace Pharma Capital

F2G raised $60M on June 20, 2016

Investors: Sectoral Asset Management, Sunstone Life Science Ventures, Aisling Capital, Merifin Capital, Novo Holdings, Advent Life Sciences and Brace Pharma Capital